Skip to main content
Tech.euFundingExplorerBeta

Abalos Therapeutics

Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.

Total raised
€43M
€43,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2021-10
latest 2021-10

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood16
base rate 44% for Series A
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds

Related news

Similar companies

same sector or country